Double Helix Optics Inc
Medtech · Private
Engineered point spread function (ePSF) microscope objective lenses with integrated phase modulation and recovery software for volumetric spatial omics imaging
- Grants
- $5.5M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Three-Dimensional Computational Optical Imaging Sensor | $941,437 | |
| Federal grant | Department of Health and Human Services · Phase I · Light engineering module for fast high-resolution whole-cell imaging | $218,223 | |
| Federal grant | Department of Health and Human Services · Phase II · Light Engineering Module for Fast High-Resolution Whole-Cell Imaging | $738,430 | |
| Federal grant | Department of Health and Human Services · Phase II · Light Engineering Module for Fast High-Resolution Whole-Cell Imaging | $722,136 | |
| Federal grant | Department of Health and Human Services · Phase I · High-resolution extended-depth phase-engineered objectives to accelerate spatial 'omics R&D through computational optics | $387,211 | |
| Federal grant | Department of Health and Human Services · Phase I · High-resolution extended-depth phase-engineered objectives to accelerate spatial 'omics RandD through computational optics | $387,211 | |
| Federal grant | Department of Health and Human Services · Phase II · High-resolution extended-depth phase-engineered objectives to accelerate spatial 'omics R&D through computational optics | $1,084,722 | |
| Federal grant | Department of Health and Human Services · Phase II · High-resolution extended-depth phase-engineered objectives to accelerate spatial 'omics R&D through computational optics | $976,236 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2069 | E-Lambda LLC | — | — |
| 2070 | 21MedTech LLC | — | — |
| 2071 | VIZMA LIFE SCIENCES INC | — | — |
| 2072 | Double Helix Optics Inc | — | — |
| 2073 | DURAMETRIX LLC | — | — |
| 2074 | ClaimDetect LLC | — | — |
| 2075 | NUPROBE USA, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- 3D Target For Optical System Characterizationgranted
- ENGINEERED POINT SPREAD FUNCTION (ePSF) OBJECTIVE LENSESapplication
- Phase Engineering And Computational Recovery For Spatial 'omicsapplication
- 3D Target For Optical System Characterizationgranted
- ENGINEERED POINT SPREAD FUNCTION (ePSF) OBJECTIVE LENSESapplication
- Method Of Using Phase Engineering And Computational Recovery For Spatial 'omicsapplication
- Engineered Point Spread Function (epsf) Objective Lensesapplication
- Phase Engineering And Computational Recovery For Spatial 'omicsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.